Sanai Health Industry Group Company Limited (HKG:1889)
0.3200
-0.0200 (-5.88%)
At close: Apr 2, 2026
HKG:1889 Revenue
In the year 2025, Sanai Health Industry Group Company had annual revenue of 85.90M CNY with 0.80% growth. Sanai Health Industry Group Company had revenue of 47.22M in the half year ending June 30, 2025, a decrease of -22.95%.
Revenue
85.90M CNY
Revenue Growth
+0.80%
P/S Ratio
0.51
Revenue / Employee
584.35K CNY
Employees
147
Market Cap
48.93M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 85.90M | 683.00K | 0.80% |
| Dec 31, 2024 | 85.22M | -22.55M | -20.92% |
| Dec 31, 2023 | 107.77M | -68.16M | -38.74% |
| Dec 31, 2022 | 175.92M | 108.32M | 160.21% |
| Dec 31, 2021 | 67.61M | -53.80M | -44.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Interlong Bio-technique Company | 1.08B |
| Kontafarma China Holdings | 914.71M |
| Wai Yuen Tong Medicine Holdings | 721.27M |
| Qianhai Health Holdings | 677.12M |
| PuraPharm Corporation | 336.11M |
| Tianda Pharmaceuticals | 322.95M |
| Pak Fah Yeow International | 199.55M |
| Extrawell Pharmaceutical Holdings | 52.65M |